We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · August 10, 2021

Efficacy of Immunotherapy as Single Treatment for Patients With NSCLC With Brain Metastases

Journal of Thoracic Oncology

 

Additional Info

Journal of Thoracic Oncology
Immunotherapy as Single Treatment for Patients With NSCLC With Brain Metastases: A Systematic Review and Meta-Analysis-the META-L-BRAIN Study
J Thorac Oncol 2021 Aug 01;16(8)1379-1391, V Teixeira Loiola de Alencar, MP Guedes Camandaroba, R Pirolli, CAZ Fogassa, VC Cordeiro de Lima

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading